MARKET

AGEN

AGEN

Agenus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.18
-0.01
-0.19%
After Hours: 5.14 -0.04 -0.77% 19:26 09/18 EDT
OPEN
5.32
PREV CLOSE
5.19
HIGH
5.45
LOW
4.850
VOLUME
7.52M
TURNOVER
--
52 WEEK HIGH
5.63
52 WEEK LOW
1.820
MARKET CAP
950.23M
P/E (TTM)
-4.5498
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average AGEN stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AGEN
Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Agenus Inc stock information, including NASDAQ:AGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGEN stock methods without spending real money on the virtual paper trading platform.